首页 > 市场调查报告书 > 医疗设备

感测器生技设备

生物感测器市场规模、份额和成长分析（按类型、产品、技术、组件、应用和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1898380

生物感测器市场规模、份额和成长分析（按类型、产品、技术、组件、应用和地区划分）—产业预测，2026-2033年

Biosensors Market Size, Share, and Growth Analysis, By Type (Sensor Patch, Embedded Device), By Product (Wearable Biosensors, Non-Wearable Biosensors), By Technology, By Component, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，生物感测器市场规模将达到 327.2 亿美元，到 2025 年将达到 353.7 亿美元，到 2033 年将达到 659.5 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.1%。

生物感测器作为一种先进的分析工具，能够将生物反应转化为可测量的电讯号，从而实现对特定化学物质的检测。这些设备通常由生物受体和感测器组成，生物受体用于识别目标分析物，感测器则将检测结果转化为可量化的数据。包括糖尿病和心血管疾病在内的慢性病盛行率不断上升，凸显了对创新诊断工具的需求，并推动了医疗保健服务的进步。此外，人口成长推动了医院和药房对医疗诊断的广泛应用，而将生物感测器整合到诊断设备中则提高了患者评估的效率和准确性。半导体製造商和医疗设备製造商之间的合作进一步加速了生物感测器市场的扩张，为各个领域的成长和发展创造了巨大的机会。

生物感测器市场驱动因素

生物感测器市场正经历显着成长，这主要得益于照护现场检测（POC）需求的不断增长，尤其是在医疗保健领域。生物感测器提供快速、高精度且便携的检测解决方案，对于后续观察慢性疾病、应对急性健康问题以及有效应对公共卫生挑战至关重要。即时检测的高效性使其在从临床到居家医疗等各种场景中广泛应用，从而推动了生物感测器市场的发展。随着医疗保健环境的不断发展，对这些创新技术的需求持续增长，进而促进了整个产业的扩张。

生物感测器市场面临的限制因素

生物感测器市场面临的主要限制因素是先进生物感测器技术的高成本。开发和製造高灵敏度和高特异性的生物感测器通常需要使用昂贵的材料和复杂的製造过程。这种经济负担会阻碍生物感测器技术的广泛应用，尤其是在资源匮乏的地区和发展中地区，在这些地区，价格承受能力（市场渗透的关键因素）是一个挑战。这项挑战限制了这些技术的应用，最终影响其在各种应用中的整合，并降低了生物感测器市场的整体成长潜力。解决这些成本问题对于促进生物感测器技术的更广泛应用至关重要。

生物感测器市场趋势

受对高效糖尿病管理解决方案日益增长的需求驱动，生物感测器市场正经历显着增长。随着糖尿病在全球的盛行率不断上升，早期诊断和持续监测变得愈发重要。生物感测器具有许多优势，例如能够精确测量胰岛素水平且经济高效，使其成为传统分析方法的更优替代方案，因为传统分析方法往往缺乏即时监测能力。这种向生物感测器技术的转变源于对持续高效病患监测的需求，使医疗专业人员能够及时采取干预措施。这促成了创新技术的进步，并推动了生物感测器技术在医疗保健领域的广泛应用。

Abbott Laboratories（USA）
Roche Diagnostics（Switzerland）
Medtronic plc（Ireland）
Bio-Rad Laboratories, Inc.（USA）
DuPont（USA）
Biosensors International Group, Ltd.（Singapore）
Cytiva（UK）
Dexcom, Inc.（USA）
Lifescan IP Holdings, LLC（USA）
Masimo Corporation（USA）
Nova Biomedical（USA）
Universal Biosensors（Australia）
ACON Laboratories, Inc.（USA）
CARDEA BIO INC.（USA）
Conductive Technologies（USA）
EarlySense（Israel）
Innovative Sensor Technology IST AG（Switzerland）
LifeSignals（USA）
NeuroSky（USA）
SD Biosensor, INC.（South Korea）

结论与建议

简介目录

Product Code: SQMIG45J2077

Biosensors Market size was valued at USD 32.72 Billion in 2024 and is poised to grow from USD 35.37 Billion in 2025 to USD 65.95 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

Biosensors serve as sophisticated analytical tools that convert biological reactions into measurable electrical signals, facilitating the detection of specific chemicals. These devices typically comprise a bioreceptor that identifies the target analyte and a transducer that converts the detection into quantifiable data. The rising prevalence of chronic illnesses, including diabetes and cardiovascular conditions, underscores the demand for innovative diagnostic tools, fostering advancements in healthcare delivery. Additionally, the growing population has spurred the availability of medical diagnostics in hospitals and pharmacies, while the incorporation of biosensors into diagnostic devices enhances efficiency and accuracy in patient assessments. Collaborations between semiconductor and medical device manufacturers are further accelerating the expansion of the biosensor market, presenting significant opportunities for growth and development across various sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biosensors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biosensors Market Segments Analysis

Global Biosensors Market is segmented by Type, Product, Technology, Component, Application and region. Based on Type, the market is segmented into Sensor Patch and Embedded Device. Based on Product, the market is segmented into Wearable Biosensors and Non-Wearable Biosensors. Based on Technology, the market is segmented into Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors and Nanomechanical Biosensors. Based on Component, the market is segmented into Bioreceptor Molecules, Biological Element and Transducer. Based on Application, the market is segmented into Poc, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages and Biodefense. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biosensors Market

The biosensors market is experiencing significant growth, fueled by the increasing need for point-of-care (POC) assays, particularly within the healthcare sector. Biosensors provide rapid, precise, and portable testing solutions that are vital for tracking chronic illnesses, addressing acute health issues, and responding effectively to public health challenges. The efficiency of POC testing fosters its widespread use across diverse environments, ranging from clinical settings to home healthcare, which in turn propels the advancement of the biosensors market. As the healthcare landscape evolves, the demand for these innovative technologies continues to rise, contributing to the overall expansion of the industry.

Restraints in the Biosensors Market

A significant constraint in the biosensors market is the elevated costs linked to advanced biosensor technology. The development and production of highly sensitive and specific biosensors typically require the use of costly materials and complex manufacturing techniques. Such financial burdens can hinder widespread adoption, particularly in resource-constrained settings and developing regions, where affordability plays a crucial role in market penetration. This challenge can limit the accessibility of these technologies, ultimately affecting their integration into various applications and reducing the overall growth potential of the biosensor market. Addressing these cost-related issues is essential for fostering broader utilization.

Market Trends of the Biosensors Market

The biosensors market is experiencing significant growth driven by the rising demand for effective diabetes management solutions. With the increasing incidence of diabetes globally, there is a heightened emphasis on early diagnosis and ongoing monitoring. Biosensors offer precise benefits, such as accurate insulin measurement and cost-effectiveness, positioning them as superior alternatives to traditional analytical methods, which often lack real-time capabilities. This shift towards biosensor technology is fueled by the need for continuous and efficient patient monitoring, enabling healthcare professionals to implement timely interventions. Consequently, the market is witnessing innovative advancements and broader adoption within the healthcare sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Patent Analysis

Global Biosensors Market Size by Type & CAGR (2026-2033)

Market Overview
Sensor Patch
Embedded Device

Global Biosensors Market Size by Product & CAGR (2026-2033)

Market Overview
Wearable Biosensors
- Wristwear
- Eyewear
- Footwear
- Neckwear
- Bodywear
- Others
Non-Wearable Biosensors

Global Biosensors Market Size by Technology & CAGR (2026-2033)

Market Overview
Electrochemical Biosensors
- Amperometric Sensors
- Potentiometric Sensors
- Conductometric Sensors
Optical Biosensors
- SPR
- Colorimetric Biosensors
- Fluorescence Biosensors
Piezoelectric Biosensors
- Acoustic Biosensors
- Microcantilever Biosensors
Thermal Biosensors
Nanomechanical Biosensors

Global Biosensors Market Size by Component & CAGR (2026-2033)

Market Overview
Bioreceptor Molecules
Biological Element
Transducer

Global Biosensors Market Size by Application & CAGR (2026-2033)

Market Overview
Poc
- Glucose Monitoring
- Cardiac Marker
- Infectious Disease Detection
- Coagulation Monitoring
- Pregnancy Testing
- Blood Gas & Electrolyte Detection
- Detection Of Tumor Or Cancer Marker
- Urinalysis Testing
- Cholesterol Testing
Home Diagnostics
- Glucose Monitoring
- Pregnancy Testing
- Cholesterol Testing
Research Labs
Environmental Monitoring
Food & Beverages
Biodefense

Global Biosensors Market Size & CAGR (2026-2033)

North America (Type, Product, Technology, Component, Application)
- US
- Canada
Europe (Type, Product, Technology, Component, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product, Technology, Component, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product, Technology, Component, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product, Technology, Component, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DuPont (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytiva (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifescan IP Holdings, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Masimo Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Universal Biosensors (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CARDEA BIO INC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conductive Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EarlySense (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovative Sensor Technology IST AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeSignals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSky (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SD Biosensor, INC. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments